Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lymphoma 3Leukemia, Myeloid, Acute 2Congenital Abnormalities 2Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Hodgkin Disease 1Extensive Stage Small Cell Lung Cancer 1Central Nervous System Neoplasms 1Carcinoma, Small Cell 1Carcinoma, Neuroendocrine 1Burkitt Lymphoma 1Brain Neoplasms 1

Interventions

Cytarabine 56Etoposide 24Daunorubicin 22Filgrastim 18Busulfan 16fludarabine phosphate 14Mitoxantrone 14Idarubicin 14Cyclophosphamide 14Peripheral Blood Stem Cell Transplantation 12tipifarnib 11Gemtuzumab 11Flow Cytometry 9Cyclosporine 9Antilymphocyte Serum 9sargramostim 8Methotrexate 8Clofarabine 8Gene Expression Profiling 7Topotecan 6Radiotherapy 6Azacitidine 6valspodar 5alvocidib 5aldesleukin 5Melphalan 5Whole-Body Irradiation 4Observation 4Methylprednisolone 4Granulocyte Colony-Stimulating Factor 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Erythroblastic, Acute × Podophyllotoxin × Clear all
NCT01127009 2015-08-13

Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia

Case Comprehensive Cancer Center

Phase 1 Completed
3 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡